Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06278415
Other study ID # P2021/Neonat/PhyCord 1
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 21, 2024
Est. completion date September 2024

Study information

Verified date February 2024
Source Queen Fabiola Children's University Hospital
Contact Anna AMORUSO
Phone +3224773250
Email anna.amoruso@hubruxelles.be
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Before birth, the baby's lungs are filled with fluid and babies do not use the lungs to breathe, as the oxygen comes from the placenta. As delivery approaches, the lungs begin to absorb the fluid. After vaginal delivery, the umbilical cord is clamped and cut after a delay that allows some of the blood in the umbilical cord and placenta to flow back into the baby. Meanwhile, as the baby breathes for the first time, the lungs fill with air and more fluid is pushed out. However, it does not always work out that way. Some babies need to be delivered via cesarean section, a surgical delivery requiring incisions through the abdominal and uterine walls. After cesarean section, the mother is often unable to hold the baby close right away as a result of her own post-surgical care. Moreover, a baby born by planned cesarean section may have breathing problems because of extra fluid staying in the lungs. Thus, the baby must breathe quicker and harder to get enough oxygen enter into the lungs. Although the baby is usually getting better within one or two days, the treatment requires close monitoring, breathing help, and nutritional help as the baby is too tired to suck and swallow milk. Sometimes, the baby cannot recover well and show greater trouble breathing needing intensive care. This further separates the mother and her baby. A possible mean to help the baby to adapt better after cesarean section while staying close to the mother is to delay cord clamping when efficient breathing is established, either spontaneously or after receiving breathing help at birth. In this study, we intend to test this procedure in term infants born by planned cesarean section and see whether the technique helps the baby to better adapt after birth and to better initiate a deep bond with the mother.


Description:

The successful transition from fetal to neonatal life is a major physiological challenge that requires the coordination of lung developmental processes, which culminate with the formation of a diffusible alveolar-capillary barrier, adequate pulmonary vasoreactivity, mature surfactant system, and clearance of lung fluid. During fetal life, gas exchange does not take place in fetal lungs but in the placenta. High pulmonary vascular resistance diverts blood flow to the left atrium through the foramen ovale and to the aorta via the ductus arteriosus. The placental circulation receives 30-50 % of the fetal cardiac output and is the major source of venous return to the fetal heart. Therefore, the umbilical venous return determines the preload for the left ventricle. Shortly before birth and during labor, the lungs undergo important transitional changes. The reabsorption of lung fluid within the airways is initiated during labor by adrenaline-induced activation of sodium channels. Uterine contractions during labor and the onset of inspiration after umbilical cord clamping generate a high transpulmonary pressure gradient leading to additional clearance of fluid from the airways into the surrounding tissue . Following the first breath and lung aeration, oxygen-induced vasodilation leads to a sudden rise in pulmonary blood flow and left atrial pressures, which closes the foramen ovale. Meanwhile, systemic vascular resistance increases above the level of pulmonary vascular resistance after placental removal, which reverses blood flow across the ductus arteriosus and induces ductal closure in response to high oxygen tension. The route of delivery can impact the success of adaptation to extrauterine life. Over the past 30 years, the rate of cesarean deliveries has increased worldwide. In Belgium, this can be as high as 20% of all deliveries. A subset of cesarean deliveries is scheduled in term infants in the absence of spontaneous labor when vaginal delivery is considered as too risky for maternal and/or child health. The so-called iterative cesarean delivery, which is usually considered as a routine and harmless option, can however alter neonatal health. By contrast with vaginal delivery, infants born at term by iterative cesarean delivery have to adapt despite larger volumes of fluid within airways and interstitial tissue resulting from a limited rise in transpulmonary pressure and adrenaline-induced fluid reabsorption. Subsequently, the retention of lung fluid is responsible for transient tachypnea of the newborn, a respiratory distress that is usually considered as mild, transient, and without sequelae. Moreover, infants born by elective cesarean delivery exhibit a higher risk of positive pressure ventilation resuscitation at birth, admission to the neonatal intensive care unit (NICU), and severe hypoxic respiratory failure requiring mechanical ventilation in the most severe cases. In addition to increased neonatal morbidity, iterative cesarean section can impact mother-infant relationship. After vaginal delivery, immediate skin-to-skin contact during the first minute after birth is the natural process recommended to support mother-infant bonding and promote early onset of breastfeeding. Despite efforts made to start skin-to-skin contact as early as possible after cesarean delivery, immediate contact is practically difficult to implement. In our institution, the infant is usually shortly separated from the mother after umbilical cord clamping to provide first care by a pediatrician before returning on the mother's chest or on the father's chest depending on parental wishes and maternal well-being during the operation. The separation between the mother and her newborn can be further extended in the case of NICU admission for transient tachypnea. Beside the route of delivery, the timing of umbilical cord clamping can profoundly affect the process of neonatal cardiorespiratory transition. Immediate cord clamping reduces the venous return to the heart, which transiently decreases heartbeats, cardiac output and cerebral blood flow before respiration initiates and pulmonary blood flow increases. Delayed cord clamping for longer than 60 seconds improves the transfusion of blood from the placenta to the newborn. Moreover, it can increase neonatal hemoglobin levels, improve long-term iron stores, and improve neurodevelopmental outcomes. Nevertheless, in both clinical research setting and daily practice, delayed cord clamping lasts rarely more than one minute during cesarean section. More recently, another approach, referred to as physiologically based cord clamping (PBCC), has been proposed to delay cord clamping up to 5 minutes after the onset of ventilation. PBCC allows to start lung aeration while on placental support and, therefore, promotes hemodynamic transition by increasing pulmonary blood flow and maintaining left ventricle preload. This strategy has been demonstrated efficient in preterm lambs and is feasible in very preterm infants, via the use of a purpose-designed resuscitation table that allows delayed cord clamping, maintenance of body temperature, and concomitant respiratory support where necessary. First experience has reported good parental acceptance of the procedure. Because PBCC has not been reported in term infants at risk of respiratory distress after birth, the present project aims to assess whether PBCC in term infants born by elective cesarean section would not be inferior to standard umbilical cord clamping with regards to adaptation to extrauterine life, respiratory morbidity, quality of mother-infant bonding, and maternal safety.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date September 2024
Est. primary completion date August 2024
Accepts healthy volunteers No
Gender All
Age group 37 Weeks to 42 Weeks
Eligibility Inclusion Criteria: Pregnant women followed-up in Brugmann University Hospital will be eligible to participate if: 1. Scheduled for cesarean delivery (business days and daily working hours) 2. Singleton pregnancy 3. Cesarean section scheduled at or after 37 weeks gestational age Exclusion Criteria: 1. Fetal anomalies (congenital malformations, anemia, growth restriction with abnormal Dopplers) 2. Abnormal placentation (placenta previa) 3. Signs of fetal distress necessitating an emergency cesarean section 4. Spontaneous labor before cesarean section 5. Maternal health issue including severe anemia (defined as hemoglobin level < 7 g/dL), preeclampsia, and bleeding disorders 6. Maternal refusal of the use of blood products. 7. General anesthesia for cesarian section 8. Planned cord blood banking 9. Total language barrier without possibility of translation

Study Design


Related Conditions & MeSH terms

  • Tachypnea
  • Transient Tachypnea of the Newborn

Intervention

Other:
Physiological based cord clamping
see Arm Description
Differed cord clamping
see Arm Description

Locations

Country Name City State
Belgium CHU Brugmann Brussels
Belgium Hôpital Universitair Des Enfants Reine Fabiola Brussels

Sponsors (4)

Lead Sponsor Collaborator
Queen Fabiola Children's University Hospital Ars Statistica, Fonds IRIS-Recherche, The Belgian Kids Fund

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Rate of neonatal mortality within 28 days of delivery
Primary Rate of neonatal resuscitation Neonatal resuscitation is defined as the use of a T-piece resuscitator for continuous airway positive pressure or intermittent positive pressure (with or without oxygen supplementation). within first 10 minutes of life
Primary Rate of neonatal respiratory morbidity Neonatal respiratory morbidity includes transient tachypnea of the newborn, air leak syndrome and respiratory distress syndrome. within first 24 hours of life
Primary Number of admission to the NICU or special care baby unit within first 72 hours of life
Secondary Success of PBCC Measured by the percentage of neonates in whom the procedure will be achieved without issue, identification of failed PBCC, and duration of stabilization with PBCC (defined as spontaneous breathing heart rate >100 bpm, oxygen saturation by pulse oximetry = 85% with inspired oxygen fraction < 0.3). within first 10 minutes of life
Secondary Time to first breath/cry Time in seconds post delivery
Secondary Changes in physiological variables during neonatal transition Physiological variables include measurements of preductal oxygen saturation by pulse oximetry (in %) and gases, as well as Apgar scores at 1, 5, and 10 minutes. within first 10 minutes of life
Secondary Changes in physiological variables during neonatal transition Physiological variables include measurements of respiratory rate and heart rate (in number per minute) within first 10 minutes of life
Secondary Changes in physiological variables during neonatal transition Physiological variables include measurements of body temperature (in degrees Celcius) within first 10 minutes of life
Secondary Changes in physiological variables during neonatal transition Physiological variables include measurements of umbilical cord venous hemoglobin (in gr/dl) within first 10 minutes of life
Secondary Changes in physiological variables during neonatal transition Physiological variables include measurements of umbilical cord pH within first 10 minutes of life
Secondary Changes in physiological variables during neonatal transition Physiological variables include measurements of Apgar scores (from 1 to 10 units on the scale, the highest scores meaning better outcome) at 1, 5 and 10 minutes within first 10 minutes of life
Secondary Early neonatal parameters Early neonatal parameters include body temperature (in degrees Celcius) at 1, 2 and 3 hours of life. within the first 3 hours of life
Secondary Early neonatal parameters Early neonatal parameters include body weight (in gramme). within first 24 hours of life
Secondary Hemoglobin level in g/dl at 48 hours of life
Secondary Bilirubin level in mg/dl at 48 hours of life
Secondary Number of neonatal adverse events including hypoglycemia, sepsis, and the need for phototherapy. within first 72 hours of live
Secondary Maternal perioperative parameters Maternal perioperative parameters include total surgical time (in minutes), intraoperative intravenous fluid volume, intraoperative blood loss, uterotonic administration, and postoperative hemoglobin level at day 1. at Day 1 post delivery
Secondary Maternal perioperative parameters Maternal perioperative parameters include intraoperative intravenous fluid volume and intraoperative blood loss (in ml), uterotonic administration, and postoperative hemoglobin level at day 1. at Day 1 post delivery
Secondary Maternal perioperative parameters Maternal perioperative parameters include uterotonic administration (Yes/No), and postoperative hemoglobin level at day 1. at Day 1 post delivery
Secondary Maternal perioperative parameters Maternal perioperative parameters include postoperative hemoglobin level (in gr/dl). at Day 1 post delivery
Secondary Number of maternal adverse events Maternal adverse events include death, blood transfusion, postpartum hemorrhage, hysterectomy, admission in the Intensive Care Unit, wound seroma, and wound cellulitis. within first 2 weeks post delivery
Secondary Rate of maternal-infant bonding breastfeeding (yes/no) up to 2 weeks post delivery
Secondary Rate of maternal-infant bonding maternal depression (measured by the Edinburgh Postnatal Depression Scale (EPDS) - score min = 0, score max = 30, higher score = worse outcome) at 2 weeks post delivery
Secondary Rate of maternal-infant bonding maternal depression (measured by the Maternal Infant Bonding Scale (MIBS) - score min = 0, score max = 24, higher score = worse outcome) at 2 weeks post delivery
Secondary Child developmental assessment The child developmental assessment is done using the Brazelton Neonatal Behavioral Assessment Scale (NBAS) - score min = 1, score max = 6, higher score = better outcome at 2 weeks postnatally
Secondary Parental satisfaction survey at 2 weeks post delivery
See also
  Status Clinical Trial Phase
Recruiting NCT01206946 - Efficacy of Antenatal Steroids in Reducing Respiratory Morbidities in Late Preterm Infants Phase 2
Completed NCT01310153 - Effect of Supine or Prone Position After Caesarean Birth N/A
Active, not recruiting NCT04780412 - Efficacy of Misoprostol in Prevention of Neonatal Respiratory Morbidity in Parturient at Early Term Elective Caesarian Section Phase 3
Completed NCT01517958 - Lung Ultrasound to Diagnose Transient Tachypnea of the Newborn (TTN) Versus Respiratory Distress Syndrome (RDS) in Neonates N/A
Withdrawn NCT03499418 - Evaluation of the Prevalence of Persistent Pulmonary Hypertension in Neonates
Completed NCT01859533 - Positive End Expiratory Pressure With A T-piece Resuscitator For Near-Term and Term Infants With Respiratory Distress Phase 2
Completed NCT03208894 - Role of Salbutamol and Furosemide in TTN Phase 3
Recruiting NCT01858129 - Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn Phase 2
Completed NCT01772381 - Dexamethasone in Prevention of Respiratory Morbidity in Elective Caesarean Section in Term Fetus N/A
Completed NCT01225029 - Fluid Management in Transient Tachypnea of the Newborn N/A
Recruiting NCT01270581 - High Flow Nasal Cannula Versus Bubble Nasal CPAP for the Treatment of Transient Tachypnea of the Newborn in Infants ≥ 35 Weeks Gestation N/A
Not yet recruiting NCT06200519 - Assessment of Diastolic Function During the Transitional Period and Infancy Using Serial Echocardiography
Completed NCT02965365 - PATET Ratio to Rule Out Transient Tachypnea of the Newborn N/A
Recruiting NCT05538780 - Diagnosis of Transient Tachypnea of Newborn
Completed NCT04722016 - LUNG ULTRASONOGRAPHY DECREASES RADIATION EXPOSURE
Recruiting NCT06270823 - Reducing Respiratory Distress After Elective Caesarean Birth Through Knee-chest-flexion: a Randomized Controlled Trial N/A
Completed NCT03006354 - nHFOV Versus nCPAP in Transient Tachypnea of the Newborn N/A
Completed NCT05006235 - Inhaled Beta-2 Agonist Versus Epinephrine For Treatment of Transient Tachypnea of Newborn (TTN) Phase 1
Recruiting NCT03346343 - Pulmonary Function Using Non-invasive Forced Oscillometry N/A
Completed NCT03165305 - The Role of Sustained Inflation on Short Term Respiratory Outcomes in Term Infants N/A